Skip to content

LNSR

LENSAR, Inc.

NASDAQ · Healthcare · Medical - Devices · US

$8.58
+4.00%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue60.3M58.4M53.5M42.2M35.4M
Cost of Revenue31.4M31.3M27.6M21.1M15.4M
Gross Profit28.9M27.1M25.9M21.1M20.0M
Operating Expenses
R&D Expense5.3M5.6M5.3M6.1M11.8M
SG&A Expense31.0M45.2M26.5M26.1M27.2M
General & Admin Expense8.7M
Selling & Marketing Expense
Other Expenses687.0K921.0K4.7M1.1M1.1M
Total Operating Expenses37.0M51.7M36.5M33.3M40.1M
Cost and Expenses68.4M83.0M64.2M54.4M55.5M
Operating Income (EBIT)(8.1M)(24.6M)(10.7M)(12.2M)(20.2M)
Non-Operating
Interest Income40.0K91.0K103.0K85.0K17.0K
Interest Expense
Net Interest Income40.0K91.0K103.0K85.0K17.0K
Other Non-Op Income/Expense42.8M(9.7M)(20.7M)(2.2M)263.0K
Non-Operating Income (excl Interest)(40.0M)9.7M(3.7M)2.2M(263.0K)
EBT (Pre-Tax Income)34.7M(34.3M)(31.4M)(14.4M)(19.9M)
Income Tax Expense
Bottom Line
Net Income34.7M(34.3M)(31.4M)(14.4M)(19.9M)
Earnings from Cont. Ops34.7M(34.3M)(31.4M)(14.4M)(19.9M)
Earnings from Discont. Ops
Bottom Line Net Income16.0M(34.3M)(31.4M)(14.4M)(19.9M)
Per Share
Basic EPS$1.27($2.87)($2.73)($1.31)($1.96)
Diluted EPS($0.33)($2.87)($2.73)($1.31)($1.96)
Revenue Per Share$4.90$4.89$4.64$3.84$3.48
Shares
Basic Shares Outstanding12.3M12.0M11.5M11.0M10.2M
Diluted Shares Outstanding23.0M12.0M11.5M11.0M10.2M
Profitability Metrics
EBITDA35.6M(29.8M)(3.0M)(10.9M)(16.5M)
D&A3.7M4.5M3.9M3.5M3.4M
EBIT31.9M(34.3M)(6.9M)(14.4M)(19.9M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026